S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
NASDAQ:EQBK

Equity Bancshares (EQBK) Stock Forecast, Price & News

$22.34
-0.42 (-1.85%)
(As of 05/31/2023 ET)
Compare
Today's Range
$22.08
$22.94
50-Day Range
$20.90
$24.95
52-Week Range
$20.50
$38.04
Volume
48,501 shs
Average Volume
51,567 shs
Market Capitalization
$345.82 million
P/E Ratio
6.65
Dividend Yield
1.79%
Price Target
$35.00

Equity Bancshares MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
56.7% Upside
$35.00 Price Target
Short Interest
Healthy
1.35% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
0.84mentions of Equity Bancshares in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$195,396 Bought Last Quarter
Proj. Earnings Growth
-0.70%
From $2.87 to $2.85 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.74 out of 5 stars

Finance Sector

286th out of 901 stocks

State Commercial Banks Industry

98th out of 192 stocks


EQBK stock logo

About Equity Bancshares (NASDAQ:EQBK) Stock

Equity Bancshares, Inc. is a bank holding company, which engages in the provision of financial services to individuals and businesses. The firm also offers commercial and personal banking services such as savings, treasury management and loans. The company was founded by Brad S. Elliott in November 2002 and is headquartered in Wichita, KS.

Receive EQBK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Equity Bancshares and its competitors with MarketBeat's FREE daily newsletter.

EQBK Stock News Headlines

EQBK - Equity Bancshares, Inc.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
8-K: EQUITY BANCSHARES INC
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Q1 2023 Equity Bancshares Inc Earnings Call
Equity Bancshares (EQBK) Tops Q1 Earnings Estimates
Equity Bancshares (EQBK) to Release Earnings on Tuesday
See More Headlines
Receive EQBK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Equity Bancshares and its competitors with MarketBeat's FREE daily newsletter.

EQBK Company Calendar

Ex-Dividend for 4/14 Dividend
3/30/2023
Dividend Payable
4/14/2023
Last Earnings
4/18/2023
Today
5/31/2023
Next Earnings (Estimated)
7/18/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
State commercial banks
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:EQBK
Employees
702
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$35.00
High Stock Price Forecast
$37.00
Low Stock Price Forecast
$33.00
Forecasted Upside/Downside
+53.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$57.69 million
Pretax Margin
27.70%

Debt

Sales & Book Value

Annual Sales
$224.21 million
Cash Flow
$4.90 per share
Book Value
$27.46 per share

Miscellaneous

Free Float
14,243,000
Market Cap
$352.63 million
Optionable
Not Optionable
Beta
0.76

Key Executives

  • Brad S. ElliottBrad S. Elliott
    Chairman & Chief Executive Officer
  • Eric R. Newell
    Chief Financial Officer & Executive Vice President
  • Chris Navratil
    Senior Vice President-Accounting & Finance
  • E. Gregory Lawson
    Chief Information Officer & Executive VP
  • Patrick J. HarbertPatrick J. Harbert
    President-Community Markets & Executive VP













EQBK Stock - Frequently Asked Questions

Should I buy or sell Equity Bancshares stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Equity Bancshares in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" EQBK shares.
View EQBK analyst ratings
or view top-rated stocks.

What is Equity Bancshares' stock price forecast for 2023?

1 brokerages have issued 1 year target prices for Equity Bancshares' stock. Their EQBK share price forecasts range from $33.00 to $37.00. On average, they anticipate the company's stock price to reach $35.00 in the next twelve months. This suggests a possible upside of 53.6% from the stock's current price.
View analysts price targets for EQBK
or view top-rated stocks among Wall Street analysts.

How have EQBK shares performed in 2023?

Equity Bancshares' stock was trading at $32.67 at the beginning of the year. Since then, EQBK stock has decreased by 30.3% and is now trading at $22.78.
View the best growth stocks for 2023 here
.

When is Equity Bancshares' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 18th 2023.
View our EQBK earnings forecast
.

How were Equity Bancshares' earnings last quarter?

Equity Bancshares, Inc. (NASDAQ:EQBK) released its earnings results on Tuesday, April, 18th. The bank reported $0.82 EPS for the quarter, beating the consensus estimate of $0.79 by $0.03. The bank had revenue of $48.20 million for the quarter, compared to the consensus estimate of $49.66 million. Equity Bancshares had a trailing twelve-month return on equity of 13.40% and a net margin of 22.86%.

How often does Equity Bancshares pay dividends? What is the dividend yield for Equity Bancshares?

Equity Bancshares declared a quarterly dividend on Monday, March 20th. Investors of record on Friday, March 31st will be given a dividend of $0.10 per share on Friday, April 14th. This represents a $0.40 annualized dividend and a dividend yield of 1.76%. The ex-dividend date of this dividend is Thursday, March 30th.
Read our dividend analysis for EQBK
.

What ETFs hold Equity Bancshares' stock?

ETFs with the largest weight of Equity Bancshares (NASDAQ:EQBK) stock in their portfolio include AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC), First Trust NASDAQ ABA Community Bank Index Fund (QABA),

Is Equity Bancshares a good dividend stock?

Equity Bancshares (NASDAQ:EQBK) pays an annual dividend of $0.40 per share and currently has a dividend yield of 1.76%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 11.90%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EQBK will have a dividend payout ratio of 14.04% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EQBK.

What is Brad Elliott's approval rating as Equity Bancshares' CEO?

45 employees have rated Equity Bancshares Chief Executive Officer Brad Elliott on Glassdoor.com. Brad Elliott has an approval rating of 56% among the company's employees. This puts Brad Elliott in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 61.0% of employees surveyed would recommend working at Equity Bancshares to a friend.

What other stocks do shareholders of Equity Bancshares own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Equity Bancshares investors own include Ionis Pharmaceuticals (IONS), Canadian Imperial Bank of Commerce (CM), Dominion Energy (D), DocuSign (DOCU), Entergy (ETR), Marathon Petroleum (MPC), (NSPH) (NSPH), People's United Financial (PBCT), Exxon Mobil (XOM).

What is Equity Bancshares' stock symbol?

Equity Bancshares trades on the NASDAQ under the ticker symbol "EQBK."

Who are Equity Bancshares' major shareholders?

Equity Bancshares' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.55%), Patriot Financial Partners GP LP (5.22%), Dimensional Fund Advisors LP (4.98%), State Street Corp (2.11%), Geode Capital Management LLC (1.83%) and Putnam Investments LLC (0.83%). Insiders that own company stock include Brad S Elliott, Brad S Elliott, Brett A Reber, Craig L Anderson, Edwin G Lawson, Eric R Newell, Gary C Allerheiligen, Gregory H Kossover, Gregory L Gaeddert, James L Berglund, John Blakeney, John G Creech, Julie A Huber, Patrick J Harbert and Tina Marie Call.
View institutional ownership trends
.

How do I buy shares of Equity Bancshares?

Shares of EQBK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Equity Bancshares' stock price today?

One share of EQBK stock can currently be purchased for approximately $22.78.

How much money does Equity Bancshares make?

Equity Bancshares (NASDAQ:EQBK) has a market capitalization of $352.63 million and generates $224.21 million in revenue each year. The bank earns $57.69 million in net income (profit) each year or $3.36 on an earnings per share basis.

How many employees does Equity Bancshares have?

The company employs 702 workers across the globe.

How can I contact Equity Bancshares?

Equity Bancshares' mailing address is 7701 EAST KELLOGG DRIVE SUITE 300, WICHITA KS, 67207. The official website for the company is www.equitybank.com. The bank can be reached via phone at (316) 612-6000, via email at cnavratil@equitybank.com, or via fax at 316-681-2325.

This page (NASDAQ:EQBK) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -